After a tumultuous year, a popular virtual care platform is trying its hand in a competitive blood testing market.

Oct 21 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab raised its full-year forecast for profit and revenue on Tuesday, banking on robust demand for its diagnostic tests, ...

Quest Diagnostics Inc. convinced a federal appeals court Thursday not to revive a class action that alleged the clinical laboratory improperly shared patients’ data with Meta Platforms Inc.

The new facility brings rapid toxicology testing, expanded capacity, and enhanced support for mental health and substance-use treatment centers across Texas. IRVINE, Calif., October 29, ...

The telehealth platform expects the new offering to add to its user base as it draws customers looking to prevent future ...

What To Know: While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP earnings per share guidance to a range of $8.58 to $8.66 from a ...

SECAUCUS, N.J. (AP) — SECAUCUS, N.J. (AP) — Quest Diagnostics Inc. (DGX) on Tuesday reported third-quarter profit of $245 million. The Secaucus, New Jersey-based company said it had profit of $2.16 ...

Watch Emmanuel Abate, Head of Genomics and Cellular Research at Cytiva host an industry panel discussion ‘Diagnostics design and manufacturing: 2025.’ He is joined by Dave Persing, Chief Technology ...

Labroots is excited to host the 16th Annual Clinical Diagnostics & Research Virtual Event Series on November 12, 2025. This premier online event unites clinicians, lab professionals, and researchers ...

Third quarter revenues of $2.82 billion, up 13.1% from 2024 Third quarter reported diluted earnings per share ("EPS") of $2.16, up 8.5% from 2024; and adjusted diluted EPS of $2.60, up 13.0% from 2024 ...

Modern healthcare systems face increasing strain from threats such as viral infection and antimicrobial resistance. Molecular diagnostics (MDx) that can be deployed in the laboratory will play a ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the testing & diagnostics services industry, including Labcorp (NYSE:LH) and its ...